Wells Fargo & Company »

Ngm Biopharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $25k 15k 1.59
2023-12-31 $12k 14k 0.86
2023-09-30 $12k 11k 1.07
2023-06-30 $44k 17k 2.59
2022-12-31 $5.0k 1.0k 5.02
2022-09-30 $19k 1.5k 13.07
2022-06-30 $24k 1.9k 13.00
2022-03-31 $193k 13k 15.25
2021-12-31 $334k 19k 17.74
2021-09-30 $384k 18k 20.97
2021-06-30 $867k 43k 20.00
2021-03-31 $460k 16k 29.11
2020-12-31 $1.1M 36k 30.26
2020-09-30 $813k 51k 15.91
2020-06-30 $1.7M 84k 19.74
2020-03-31 $458k 37k 12.34
2019-12-31 $469k 25k 18.52
2019-09-30 $47k 3.4k 13.78
2019-06-30 $1.0k 50 20.00